Table 2 Predictors of mortality among a sample of HIV infected cohorts of children on anti-retroviral treatment in Mekelle hospital, Northern Ethiopia
Variables | P-value | HR | [95% CI] | |
|---|---|---|---|---|
Age in months at ART initiation | ||||
≥120 | 1.00 | |||
60-120 | 0.365 | 0.499 | 0.111 | 2.248 |
36-59 | 0.305 | 0.303 | 0.031 | 2.963 |
18-35 | 0.941 | 0.943 | 0.201 | 4.433 |
<18 | 0.036 | 4.387 | 1.150 | 17.410 |
Gender | 1.00 | |||
Male | 0.518 | 0.723 | 0.271 | 1.932 |
Female | ||||
TB at baseline | ||||
No | 1.00 | |||
Yes | 0.864 | 1.143 | 0.248 | 5.276 |
Primary care giver | ||||
Parents | 1.00 | |||
Relatives | 0.132 | 0.209 | 0.027 | 1.605 |
Guardian/orphan | 0.343 | 0.329 | 0.033 | 3.271 |
Chronic Diarrhea | ||||
No | 1.00 | 1.00 | ||
Yes | 0.008 | 4.637 | 1.502 | 14.314 |
Hemoglobin level | ||||
≥8 g/dl | ||||
<8 g/dl | 0.015 | 3.769 | 1.294 | 10.979 |
CD4 percentage | ||||
≥10% | 1.00 | |||
<10% | 0.029 | 2.976 | 1.115 | 7.944 |
WHO clinical stage | ||||
Stage I & II | 1.00 | |||
Stage III & IV | 0.048 | 4.457 | 1.010 | 19.664 |